Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 86 entries
Sorted by: Best Match Show Resources per page
Use of engaging review application exercises to enhance understanding of critical concepts prior to summative examinations

engineering education

Cusick JK.
GSID: MN8yue3sHH8J
JK Cusick, L Fitzpatrick, P Khansari - Pharmacy Education, 2019 - ortofonshop.com

Two distinct and engaging review application exercises were created in an immunology class for third-year pharmacy students that utilised the Team-Based Learning (TBL) …

Cite
Cusick, J. K., Fitzpatrick, L., & Khansari, P. (2019). Use of engaging review application exercises to enhance understanding of critical concepts prior to summative examinations. Pharmacy Education, 19, 232-241.
Cusick, John K., Leo Fitzpatrick, and Parto Khansari. "Use of engaging review application exercises to enhance understanding of critical concepts prior to summative examinations." Pharmacy Education 19 (2019): 232-241.
Copy Download .nbib Format: MLA
NF- kappa B and chemoresistance: potentiation of cancer drugs via inhibition of NF- kappa B.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

Cusack JC, Liu R, Baldwin AS.
PMID: 11504498
Drug Resist Updat. 1999 Aug;2(4):271-273. doi: 10.1054/drup.1999.0094.

No abstract available.

Cite
Cusack JC, Liu R, Baldwin AS. NF- kappa B and chemoresistance: potentiation of cancer drugs via inhibition of NF- kappa B. Drug Resist Updat. 1999;2(4):271-273doi: 10.1054/drup.1999.0094.
Cusack, J. C., Liu, R., & Baldwin, A. S. (1999). NF- kappa B and chemoresistance: potentiation of cancer drugs via inhibition of NF- kappa B. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 2(4), 271-273. https://doi.org/10.1054/drup.1999.0094
Cusack, James C., et al. "NF- kappa B and chemoresistance: potentiation of cancer drugs via inhibition of NF- kappa B." Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy vol. 2,4 (1999): 271-273. doi: https://doi.org/10.1054/drup.1999.0094
Cusack JC, Liu R, Baldwin AS. NF- kappa B and chemoresistance: potentiation of cancer drugs via inhibition of NF- kappa B. Drug Resist Updat. 1999 Aug;2(4):271-273. doi: 10.1054/drup.1999.0094. PMID: 11504498.
Copy Download .nbib Format: NLM
A feasibility study to investigate the use of a bupivacaine-collagen implant (XaraColl) for postoperative analgesia following laparoscopic surgery.

Journal of pain research

Hemsen L, Cusack SL, Minkowitz HS, Kuss ME.
PMID: 23390367
J Pain Res. 2013;6:79-85. doi: 10.2147/JPR.S40158. Epub 2013 Feb 01.

BACKGROUND: XaraColl, a collagen-based implant that delivers bupivacaine to sites of surgical trauma, has been shown to reduce postoperative pain and use of opioid analgesia in patients undergoing open surgery. We therefore designed and conducted a preliminary feasibility study...

Cite
Hemsen L, Cusack SL, Minkowitz HS, et al. A feasibility study to investigate the use of a bupivacaine-collagen implant (XaraColl) for postoperative analgesia following laparoscopic surgery. J Pain Res. 2013;6:79-85doi: 10.2147/JPR.S40158.
Hemsen, L., Cusack, S. L., Minkowitz, H. S., & Kuss, M. E. (2013). A feasibility study to investigate the use of a bupivacaine-collagen implant (XaraColl) for postoperative analgesia following laparoscopic surgery. Journal of pain research, 679-85. https://doi.org/10.2147/JPR.S40158
Hemsen, Lisa, et al. "A feasibility study to investigate the use of a bupivacaine-collagen implant (XaraColl) for postoperative analgesia following laparoscopic surgery." Journal of pain research vol. 6 (2013): 79-85. doi: https://doi.org/10.2147/JPR.S40158
Hemsen L, Cusack SL, Minkowitz HS, Kuss ME. A feasibility study to investigate the use of a bupivacaine-collagen implant (XaraColl) for postoperative analgesia following laparoscopic surgery. J Pain Res. 2013;6:79-85. doi: 10.2147/JPR.S40158. Epub 2013 Feb 01. PMID: 23390367; PMCID: PMC3564459.
Copy Download .nbib Format: NLM
Electronic structure of InAs/GaAs self-assembled quantum dots.

Physical review. B, Condensed matter

Briddon PR, Cusack MA, Jaros M.
PMID: 9986162
Phys Rev B Condens Matter. 1996 Jul 15;54(4):R2300-R2303. doi: 10.1103/physrevb.54.r2300.

No abstract available.

Cite
Briddon PR, Cusack MA, Jaros M. Electronic structure of InAs/GaAs self-assembled quantum dots. Phys Rev B Condens Matter. 1996;54(4):R2300-R2303doi: 10.1103/physrevb.54.r2300.
Briddon, P. R., Cusack, M. A., & Jaros, M. (1996). Electronic structure of InAs/GaAs self-assembled quantum dots. Physical review. B, Condensed matter, 54(4), R2300-R2303. https://doi.org/10.1103/physrevb.54.r2300
Briddon, et al. "Electronic structure of InAs/GaAs self-assembled quantum dots." Physical review. B, Condensed matter vol. 54,4 (1996): R2300-R2303. doi: https://doi.org/10.1103/physrevb.54.r2300
Briddon PR, Cusack MA, Jaros M. Electronic structure of InAs/GaAs self-assembled quantum dots. Phys Rev B Condens Matter. 1996 Jul 15;54(4):R2300-R2303. doi: 10.1103/physrevb.54.r2300. PMID: 9986162.
Copy Download .nbib Format: NLM
Role of localization in determining second-order optical nonlinearities in p-type GaAs-AlAs asymmetric quantum wells.

Physical review. B, Condensed matter

Cusack MA, Jaros M, Shaw MJ.
PMID: 10010813
Phys Rev B Condens Matter. 1994 Jun 15;49(23):16575-16580. doi: 10.1103/physrevb.49.16575.

No abstract available.

Cite
Cusack MA, Jaros M, Shaw MJ. Role of localization in determining second-order optical nonlinearities in p-type GaAs-AlAs asymmetric quantum wells. Phys Rev B Condens Matter. 1994;49(23):16575-16580doi: 10.1103/physrevb.49.16575.
Cusack, M. A., Jaros, M., & Shaw, M. J. (1994). Role of localization in determining second-order optical nonlinearities in p-type GaAs-AlAs asymmetric quantum wells. Physical review. B, Condensed matter, 49(23), 16575-16580. https://doi.org/10.1103/physrevb.49.16575
Cusack, et al. "Role of localization in determining second-order optical nonlinearities in p-type GaAs-AlAs asymmetric quantum wells." Physical review. B, Condensed matter vol. 49,23 (1994): 16575-16580. doi: https://doi.org/10.1103/physrevb.49.16575
Cusack MA, Jaros M, Shaw MJ. Role of localization in determining second-order optical nonlinearities in p-type GaAs-AlAs asymmetric quantum wells. Phys Rev B Condens Matter. 1994 Jun 15;49(23):16575-16580. doi: 10.1103/physrevb.49.16575. PMID: 10010813.
Copy Download .nbib Format: NLM
Update on the Treatment of Spontaneous Intraparenchymal Hemorrhage: Medical and Interventional Management.

Current treatment options in neurology

Cusack TJ, Carhuapoma JR, Ziai WC.
PMID: 29397452
Curr Treat Options Neurol. 2018 Feb 03;20(1):1. doi: 10.1007/s11940-018-0486-5.

PURPOSE OF REVIEW: Spontaneous intraparenchymal hemorrhage (IPH) is a prominent challenge faced globally by neurosurgeons, neurologists, and intensivists. Over the past few decades, basic and clinical research efforts have been undertaken with the goal of delineating biologically and evidence-based...

Cite
Cusack TJ, Carhuapoma JR, Ziai WC. Update on the Treatment of Spontaneous Intraparenchymal Hemorrhage: Medical and Interventional Management. Curr Treat Options Neurol. 2018;20(1):1doi: 10.1007/s11940-018-0486-5.
Cusack, T. J., Carhuapoma, J. R., & Ziai, W. C. (2018). Update on the Treatment of Spontaneous Intraparenchymal Hemorrhage: Medical and Interventional Management. Current treatment options in neurology, 20(1), 1. https://doi.org/10.1007/s11940-018-0486-5
Cusack, Thomas J, et al. "Update on the Treatment of Spontaneous Intraparenchymal Hemorrhage: Medical and Interventional Management." Current treatment options in neurology vol. 20,1 (2018): 1. doi: https://doi.org/10.1007/s11940-018-0486-5
Cusack TJ, Carhuapoma JR, Ziai WC. Update on the Treatment of Spontaneous Intraparenchymal Hemorrhage: Medical and Interventional Management. Curr Treat Options Neurol. 2018 Feb 03;20(1):1. doi: 10.1007/s11940-018-0486-5. PMID: 29397452.
Copy Download .nbib Format: NLM
Clinical impact of PET/MRI in oligometastatic colorectal cancer.

British journal of cancer

Furtado FS, Suarez-Weiss KE, Vangel M, Clark JW, Cusack JC, Hong T, Blaszkowsky L, Wo J, Striar R, Umutlu L, Daldrup-Link HE, Groshar D, Rocco R, Bordeianou L, Anderson MA, Mojtahed A, Qadan M, Ferrone C, Catalano OA.
PMID: 34282295
Br J Cancer. 2021 Sep;125(7):975-982. doi: 10.1038/s41416-021-01494-8. Epub 2021 Jul 19.

BACKGROUND: Oligometastatic colorectal cancer (CRC) is potentially curable and demands individualised strategies.METHODS: This single-centre retrospective study investigated if positron emission tomography (PET)/magnetic resonance imaging (MR) had a clinical impact on oligometastatic CRC relative to the standard of care imaging...

Cite
Furtado FS, Suarez-Weiss KE, Vangel M, et al. Clinical impact of PET/MRI in oligometastatic colorectal cancer. Br J Cancer. 2021;125(7):975-982doi: 10.1038/s41416-021-01494-8.
Furtado, F. S., Suarez-Weiss, K. E., Vangel, M., Clark, J. W., Cusack, J. C., Hong, T., Blaszkowsky, L., Wo, J., Striar, R., Umutlu, L., Daldrup-Link, H. E., Groshar, D., Rocco, R., Bordeianou, L., Anderson, M. A., Mojtahed, A., Qadan, M., Ferrone, C., & Catalano, O. A. (2021). Clinical impact of PET/MRI in oligometastatic colorectal cancer. British journal of cancer, 125(7), 975-982. https://doi.org/10.1038/s41416-021-01494-8
Furtado, Felipe S, et al. "Clinical impact of PET/MRI in oligometastatic colorectal cancer." British journal of cancer vol. 125,7 (2021): 975-982. doi: https://doi.org/10.1038/s41416-021-01494-8
Furtado FS, Suarez-Weiss KE, Vangel M, Clark JW, Cusack JC, Hong T, Blaszkowsky L, Wo J, Striar R, Umutlu L, Daldrup-Link HE, Groshar D, Rocco R, Bordeianou L, Anderson MA, Mojtahed A, Qadan M, Ferrone C, Catalano OA. Clinical impact of PET/MRI in oligometastatic colorectal cancer. Br J Cancer. 2021 Sep;125(7):975-982. doi: 10.1038/s41416-021-01494-8. Epub 2021 Jul 19. PMID: 34282295; PMCID: PMC8476553.
Copy Download .nbib Format: NLM
Measuring the intensity of conflicts in conservation.

Conservation letters

Cusack JJ, Bradfer-Lawrence T, Baynham-Herd Z, Castelló Y Tickell S, Duporge I, Hegre H, Moreno Zárate L, Naude V, Nijhawan S, Wilson J, Zambrano Cortes DG, Bunnefeld N.
PMID: 34434253
Conserv Lett. 2021 May-Jun;14(3):e12783. doi: 10.1111/conl.12783. Epub 2021 Jan 11.

Conflicts between the interests of biodiversity conservation and other human activities pose a major threat to natural ecosystems and human well-being, yet few methods exist to quantify their intensity and model their dynamics. We develop a categorization of conflict...

Cite
Cusack JJ, Bradfer-Lawrence T, Baynham-Herd Z, et al. Measuring the intensity of conflicts in conservation. Conserv Lett. 2021;14(3):e12783doi: 10.1111/conl.12783.
Cusack, J. J., Bradfer-Lawrence, T., Baynham-Herd, Z., Castelló Y Tickell, S., Duporge, I., Hegre, H., Moreno Zárate, L., Naude, V., Nijhawan, S., Wilson, J., Zambrano Cortes, D. G., & Bunnefeld, N. (2021). Measuring the intensity of conflicts in conservation. Conservation letters, 14(3), e12783. https://doi.org/10.1111/conl.12783
Cusack, Jeremy J, et al. "Measuring the intensity of conflicts in conservation." Conservation letters vol. 14,3 (2021): e12783. doi: https://doi.org/10.1111/conl.12783
Cusack JJ, Bradfer-Lawrence T, Baynham-Herd Z, Castelló Y Tickell S, Duporge I, Hegre H, Moreno Zárate L, Naude V, Nijhawan S, Wilson J, Zambrano Cortes DG, Bunnefeld N. Measuring the intensity of conflicts in conservation. Conserv Lett. 2021 May-Jun;14(3):e12783. doi: 10.1111/conl.12783. Epub 2021 Jan 11. PMID: 34434253; PMCID: PMC8365684.
Copy Download .nbib Format: NLM
Classification and diagnosis: using the full terminology.

Diabetes care

Cusack RP.
PMID: 6872814
Diabetes Care. 1983 May-Jun;6(3):312-3. doi: 10.2337/diacare.6.3.312.

No abstract available.

Cite
Cusack RP. Classification and diagnosis: using the full terminology. Diabetes Care. 1983;6(3):312-3doi: 10.2337/diacare.6.3.312.
Cusack, R. P. (1983). Classification and diagnosis: using the full terminology. Diabetes care, 6(3), 312-3. https://doi.org/10.2337/diacare.6.3.312
Cusack, R P. "Classification and diagnosis: using the full terminology." Diabetes care vol. 6,3 (1983): 312-3. doi: https://doi.org/10.2337/diacare.6.3.312
Cusack RP. Classification and diagnosis: using the full terminology. Diabetes Care. 1983 May-Jun;6(3):312-3. doi: 10.2337/diacare.6.3.312. PMID: 6872814.
Copy Download .nbib Format: NLM
The longitudinal buffering effects of resilience on alcohol use outcomes.

Psychological trauma : theory, research, practice and policy

Cusack SE, Bountress KE, Sheerin CM, Spit For Science Work Group, Dick DM, Amstadter AB.
PMID: 34843351
Psychol Trauma. 2021 Nov 29; doi: 10.1037/tra0001156. Epub 2021 Nov 29.

OBJECTIVE: Traumatic events (TE) are a risk factor for alcohol use disorder (AUD). Resilience may be protective of the effects of TE exposure, but few studies have longitudinally tested the buffering hypothesis. Thus, the present study aimed to fill...

Cite
Cusack SE, Bountress KE, Sheerin CM, et al. The longitudinal buffering effects of resilience on alcohol use outcomes. Psychol Trauma. 2021;doi: 10.1037/tra0001156.
Cusack, S. E., Bountress, K. E., Sheerin, C. M., Spit For Science Work Group, Dick, D. M., & Amstadter, A. B. (2021). The longitudinal buffering effects of resilience on alcohol use outcomes. Psychological trauma : theory, research, practice and policy, . https://doi.org/10.1037/tra0001156
Cusack, Shannon E, et al. "The longitudinal buffering effects of resilience on alcohol use outcomes." Psychological trauma : theory, research, practice and policy vol. (2021). doi: https://doi.org/10.1037/tra0001156
Cusack SE, Bountress KE, Sheerin CM, Spit For Science Work Group, Dick DM, Amstadter AB. The longitudinal buffering effects of resilience on alcohol use outcomes. Psychol Trauma. 2021 Nov 29; doi: 10.1037/tra0001156. Epub 2021 Nov 29. PMID: 34843351.
Copy Download .nbib Format: NLM
The Lancet Commission on the future of care and clinical research in autism.

Lancet (London, England)

Lord C, Charman T, Havdahl A, Carbone P, Anagnostou E, Boyd B, Carr T, de Vries PJ, Dissanayake C, Divan G, Freitag CM, Gotelli MM, Kasari C, Knapp M, Mundy P, Plank A, Scahill L, Servili C, Shattuck P, Simonoff E, Singer AT, Slonims V, Wang PP, Ysrraelit MC, Jellett R, Pickles A, Cusack J, Howlin P, Szatmari P, Holbrook A, Toolan C, McCauley JB.
PMID: 34883054
Lancet. 2021 Dec 06; doi: 10.1016/S0140-6736(21)01541-5. Epub 2021 Dec 06.

No abstract available.

Cite
Lord C, Charman T, Havdahl A, et al. The Lancet Commission on the future of care and clinical research in autism. Lancet. 2021;doi: 10.1016/S0140-6736(21)01541-5.
Lord, C., Charman, T., Havdahl, A., Carbone, P., Anagnostou, E., Boyd, B., Carr, T., de Vries, P. J., Dissanayake, C., Divan, G., Freitag, C. M., Gotelli, M. M., Kasari, C., Knapp, M., Mundy, P., Plank, A., Scahill, L., Servili, C., Shattuck, P., Simonoff, E., Singer, A. T., Slonims, V., Wang, P. P., Ysrraelit, M. C., Jellett, R., Pickles, A., Cusack, J., Howlin, P., Szatmari, P., Holbrook, A., Toolan, C., & McCauley, J. B. (2021). The Lancet Commission on the future of care and clinical research in autism. Lancet (London, England), . https://doi.org/10.1016/S0140-6736(21)01541-5
Lord, Catherine, et al. "The Lancet Commission on the future of care and clinical research in autism." Lancet (London, England) vol. (2021). doi: https://doi.org/10.1016/S0140-6736(21)01541-5
Lord C, Charman T, Havdahl A, Carbone P, Anagnostou E, Boyd B, Carr T, de Vries PJ, Dissanayake C, Divan G, Freitag CM, Gotelli MM, Kasari C, Knapp M, Mundy P, Plank A, Scahill L, Servili C, Shattuck P, Simonoff E, Singer AT, Slonims V, Wang PP, Ysrraelit MC, Jellett R, Pickles A, Cusack J, Howlin P, Szatmari P, Holbrook A, Toolan C, McCauley JB. The Lancet Commission on the future of care and clinical research in autism. Lancet. 2021 Dec 06; doi: 10.1016/S0140-6736(21)01541-5. Epub 2021 Dec 06. PMID: 34883054.
Copy Download .nbib Format: NLM
The Anniston Community Health Survey.

Journal of environmental health

Cusack C, Pavuk M, Dutton N, Yang E, Serio T.
PMID: 34732942
J Environ Health. 2020 Sep;83(2):38-41.

As part of our continued effort to highlight innovative approaches to improve the health and environment of communities, the

Cite
Cusack C, Pavuk M, Dutton N, et al. The Anniston Community Health Survey. J Environ Health. 2020;83(2):38-41
Cusack, C., Pavuk, M., Dutton, N., Yang, E., & Serio, T. (2020). The Anniston Community Health Survey. Journal of environmental health, 83(2), 38-41.
Cusack, Caroline, et al. "The Anniston Community Health Survey." Journal of environmental health vol. 83,2 (2020): 38-41.
Cusack C, Pavuk M, Dutton N, Yang E, Serio T. The Anniston Community Health Survey. J Environ Health. 2020 Sep;83(2):38-41. PMID: 34732942; PMCID: PMC8563022.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 86 entries